Jason A. Wilken

1.8k total citations
37 papers, 1.0k citations indexed

About

Jason A. Wilken is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Jason A. Wilken has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Jason A. Wilken's work include HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Fungal Infections and Studies (7 papers). Jason A. Wilken is often cited by papers focused on HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Fungal Infections and Studies (7 papers). Jason A. Wilken collaborates with scholars based in United States, France and Puerto Rico. Jason A. Wilken's co-authors include Nita J. Maihle, Andre T. Baron, Jacqueline M. Lafky, Murli Narayan, Lyndsay N. Harris, Barbara L. Materna, Jennifer McNary, Kimberly K. Leslie, Duc J. Vugia and Gayle C. Windham and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Biochemistry.

In The Last Decade

Jason A. Wilken

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason A. Wilken United States 17 385 349 204 133 132 37 1.0k
Kelly L. Bolton United States 19 528 1.4× 384 1.1× 72 0.4× 55 0.4× 167 1.3× 69 1.7k
Roopa Hariprasad India 16 291 0.8× 178 0.5× 95 0.5× 215 1.6× 43 0.3× 78 968
Dorothy Jane Huang Switzerland 18 298 0.8× 165 0.5× 33 0.2× 195 1.5× 128 1.0× 60 1.1k
Susanne Hofer Austria 20 156 0.4× 303 0.9× 123 0.6× 130 1.0× 30 0.2× 49 1.1k
David R. Risser United States 9 435 1.1× 127 0.4× 55 0.3× 212 1.6× 184 1.4× 13 1.1k
Garth Funston United Kingdom 13 234 0.6× 142 0.4× 40 0.2× 77 0.6× 122 0.9× 35 678
Pengtao Bao China 11 206 0.5× 96 0.3× 79 0.4× 67 0.5× 79 0.6× 28 864
Helen D. Bailey Australia 23 380 1.0× 143 0.4× 96 0.5× 79 0.6× 193 1.5× 86 1.4k
Van Dinh Tran Australia 18 283 0.7× 151 0.4× 101 0.5× 193 1.5× 110 0.8× 54 918
Sharmistha Ghosh United States 18 211 0.5× 356 1.0× 70 0.3× 98 0.7× 84 0.6× 29 1.2k

Countries citing papers authored by Jason A. Wilken

Since Specialization
Citations

This map shows the geographic impact of Jason A. Wilken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason A. Wilken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason A. Wilken more than expected).

Fields of papers citing papers by Jason A. Wilken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason A. Wilken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason A. Wilken. The network helps show where Jason A. Wilken may publish in the future.

Co-authorship network of co-authors of Jason A. Wilken

This figure shows the co-authorship network connecting the top 25 collaborators of Jason A. Wilken. A scholar is included among the top collaborators of Jason A. Wilken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason A. Wilken. Jason A. Wilken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heinzerling, Amy, Ellora Karmarkar, Kathleen R. Attfield, et al.. (2020). Severe Lung Injury Associated With Use of e-Cigarette, or Vaping, Products—California, 2019. JAMA Internal Medicine. 180(6). 861–861. 35 indexed citations
2.
3.
Wilken, Jason A., Janet N. Arno, Robert J. Harrison, et al.. (2016). Occupational HIV Transmission Among Male Adult Film Performers — Multiple States, 2014. MMWR Morbidity and Mortality Weekly Report. 65(5). 110–114. 6 indexed citations
4.
Dowell, Chad, et al.. (2015). Assessment of emergency responders after a vinyl chloride release from a train derailment - New Jersey, 2012.. PubMed. 63(53). 1233–7. 11 indexed citations
5.
Wilken, Jason A., et al.. (2015). Exposures and symptoms among workers after an offsite train derailment and vinyl chloride release. American Journal of Disaster Medicine. 10(2). 153–165. 3 indexed citations
6.
Wilken, Jason A., Patricia Márquez, Dawn Terashita, et al.. (2014). Coccidioidomycosis among cast and crew members at an outdoor television filming event--California, 2012.. PubMed. 63(15). 321–4. 19 indexed citations
7.
Wilken, Jason A.. (2013). Preliminary Report of An Outbreak of Coccidioidomycosis Among Solar Power Farm Construction Workers — California, 2012–2013. 1 indexed citations
8.
Leslie, Kimberly K., Michael W. Sill, Edgar Fischer, et al.. (2013). A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: A Gynecologic Oncology Group study. Gynecologic Oncology. 129(3). 486–494. 46 indexed citations
9.
Wilken, Jason A., Sarah Cross, Alessandro D. Santin, et al.. (2012). EGFR/HER-Targeted Therapeutics In Ovarian Cancer. Future Medicinal Chemistry. 4(4). 447–469. 50 indexed citations
10.
Albitar, Lina, et al.. (2010). EGFR isoforms and gene regulation in human endometrial cancer cells. Molecular Cancer. 9(1). 166–166. 44 indexed citations
11.
Wilken, Jason A., et al.. (2010). Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics. Journal of Ovarian Research. 3(1). 7–7. 42 indexed citations
12.
Wilken, Jason A. & Nita J. Maihle. (2010). Primary trastuzumab resistance: new tricks for an old drug. Annals of the New York Academy of Sciences. 1210(1). 53–65. 59 indexed citations
13.
Baron, Andre T., Jason A. Wilken, Daniel Haggstrom, S. Goodrich, & Nita J. Maihle. (2009). Clinical implementation of soluble EGFR (sEGFR) as a theragnostic serum biomarker of breast, lung and ovarian cancer.. PubMed. 12(5). 302–8. 33 indexed citations
14.
Narayan, Murli, et al.. (2009). Trastuzumab-Induced HER Reprogramming in “Resistant” Breast Carcinoma Cells. Cancer Research. 69(6). 2191–2194. 184 indexed citations
15.
Lafky, Jacqueline M., Jason A. Wilken, Andre T. Baron, & Nita J. Maihle. (2008). Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1785(2). 232–265. 178 indexed citations
16.
Wilken, Jason A. & Elliott Bedows. (2007). A Novel Four-Amino Acid Determinant Defines Conformational Freedom within Chorionic Gonadotropin β-Subunits. Biochemistry. 46(14). 4417–4424. 1 indexed citations
17.
Singh, Jaswant, Gausal A. Khan, Leo Kinarsky, et al.. (2004). Identification of Disulfide Bonds among the Nine Core 2 N-Acetylglucosaminyltransferase-M Cysteines Conserved in the Mucin β6-N-Acetylglucosaminyltransferase Family. Journal of Biological Chemistry. 279(37). 38969–38977. 6 indexed citations
18.
Wilken, Jason A., et al.. (2002). Comparison of chorionic gonadotropin expression in human and macaque (Macaca fascicularis) trophoblasts. American Journal of Primatology. 56(2). 89–97. 4 indexed citations
19.
Darling, Ryan J., Jason A. Wilken, Amanda K. Lindholm‐Perry, et al.. (2001). Functional Contributions of Noncysteine Residues within the Cystine Knots of Human Chorionic Gonadotropin Subunits. Journal of Biological Chemistry. 276(14). 10692–10699. 7 indexed citations
20.
Darling, Ryan J., Jason A. Wilken, Raymond W. Ruddon, & Elliott Bedows. (2000). Intracellular Folding Pathway of the Cystine Knot-Containing Glycoprotein Hormone α-Subunit. Biochemistry. 40(2). 577–585. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelly L. Bolton Breakdown of academic impact, for papers by Roopa Hariprasad Breakdown of academic impact, for papers by Dorothy Jane Huang Breakdown of academic impact, for papers by Susanne Hofer Breakdown of academic impact, for papers by David R. Risser Breakdown of academic impact, for papers by Garth Funston Breakdown of academic impact, for papers by Pengtao Bao Breakdown of academic impact, for papers by Helen D. Bailey Breakdown of academic impact, for papers by Van Dinh Tran Breakdown of academic impact, for papers by Sharmistha Ghosh
Rankless by CCL
2026